{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:26:11Z","timestamp":1781843171529,"version":"3.54.5"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.dadr.2025.100339","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T17:27:37Z","timestamp":1745515657000},"page":"100339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Methadone-involved overdose deaths in urban and rural communities before and after the public health emergency flexibilities for methadone take-home doses"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-0463","authenticated-orcid":false,"given":"Rebecca Arden","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry R.","family":"Kranzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanmarie","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2025.100339_bib1","article-title":"Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore","volume":"145","author":"Abidogun","year":"2023","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13011-023-00564-9","article-title":"The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review","volume":"18","author":"Adams","year":"2023","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"key":"10.1016\/j.dadr.2025.100339_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109801","article-title":"Availability of timely methadone treatment in the United States and Canada during COVID-19: a census tract-level analysis","volume":"245","author":"Amram","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100339_bib4","doi-asserted-by":"crossref","unstructured":"Baicker K., Svoronos T. Testing the validity of the single interrupted time series design. NBER Working Paper 26080. July 2019. Available from: https:\/\/www.nber.org\/papers\/w26080.","DOI":"10.3386\/w26080"},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jrh.12503","article-title":"Community attitudes toward opioid use disorder and medication for opioid use disorder in a rural Appalachian County","volume":"37","author":"Beachler","year":"2021","journal-title":"J. Rural Health"},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib6","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J. Epidemiol."},{"issue":"6","key":"10.1016\/j.dadr.2025.100339_bib7","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/ije\/dyy135","article-title":"The use of controls in interrupted time series studies of public health interventions","volume":"47","author":"Bernal","year":"2018","journal-title":"Int J. Epidemiol."},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/16066359.2022.2101640","article-title":"Social support is associated with reduced stigma and shame in a sample of rural and small urban adults in methadone treatment","volume":"31","author":"Broman","year":"2023","journal-title":"Addict. Res. Theory"},{"key":"10.1016\/j.dadr.2025.100339_bib9","article-title":"Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: rural differences","volume":"155","author":"Brown","year":"2023","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"11","key":"10.1016\/j.dadr.2025.100339_bib10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41386-023-01601-8","article-title":"Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis","volume":"48","author":"Butelman","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.dadr.2025.100339_bib11","doi-asserted-by":"crossref","DOI":"10.1353\/eca.2023.a935412","article-title":"Accounting for the widening mortality gap between American adults with and without a BA","author":"Case","year":"2023","journal-title":"Brook. Pap. Econ. Act."},{"key":"10.1016\/j.dadr.2025.100339_bib12","unstructured":"Center for Substance Abuse Treatment. Substance Abuse: Clinical Issues in Intensive Outpatient Treatment. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2006. (Treatment Improvement Protocol (TIP) Series, No. 47.) Appendix B. Urine Collection and Testing Procedures and Alternative Methods for Monitoring Drug Use."},{"key":"10.1016\/j.dadr.2025.100339_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104141","article-title":"Typology of laws restricting access to methadone treatment in the United States: a latent class analysis","volume":"119","author":"Conway","year":"2023","journal-title":"Int J. Drug Policy"},{"issue":"8","key":"10.1016\/j.dadr.2025.100339_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hup.630","article-title":"The effects of methadone and its role in fatalities","volume":"19","author":"Corkery","year":"2004","journal-title":"Hum. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.dadr.2025.100339_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a112321","article-title":"The effect of regression to the mean in epidemiologic and clinical studies","volume":"104","author":"Davis","year":"1976","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.dadr.2025.100339_bib16","series-title":"Office of the Inspector General. Opioid treatment programs reported challenges encountered during the COVID-19 pandemic and actions taken to address them","first-page":"A-09020","author":"Department of Health and Human Services","year":"2020"},{"key":"10.1016\/j.dadr.2025.100339_bib17","unstructured":"Dooling, B.C.E. & Stanley, L.E. 2021. Unsupervised use of opioid treatment medications: Report II of the extending pandemic flexibilities for opioid use disorder treatment project. GW Regulatory Studies Center. \u3008https:\/\/regulatorystudies.columbian.gwu.edu\/\u3009unsupervised-use-opioid-treatment-medications."},{"issue":"3","key":"10.1016\/j.dadr.2025.100339_bib18","article-title":"Fentanyl-driven acceleration of racial, gender and geographical disparities in drug overdose deaths in the United States","volume":"3","author":"D'Orsogna","year":"2023","journal-title":"PLOS Glob. Public Health"},{"issue":"4","key":"10.1016\/j.dadr.2025.100339_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"STROBE initiative. the strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.dadr.2025.100339_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2020.113470","article-title":"Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities","volume":"268","author":"Ezell","year":"2021","journal-title":"Soc. Sci. Med"},{"key":"10.1016\/j.dadr.2025.100339_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108276","article-title":"Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19","volume":"123","author":"Figgatt","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","article-title":"It\u2019s like Liquid Handcuffs: the effects of take-home policies on Methadone Maintenance Treatment (MMT) patients\u2019 lives","volume":"18","author":"Frank","year":"2021","journal-title":"Harm Reduct. J."},{"issue":"7","key":"10.1016\/j.dadr.2025.100339_bib23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2105\/AJPH.2021.306256","article-title":"COVID-19 and the Drug Overdose Crisis: uncovering the deadliest 10 months in the United States, January-July 2020","volume":"111","author":"Friedman","year":"2021","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2025.100339_bib24","article-title":"State guidance and system changes related to COVID-19: impact on opioid treatment programs","volume":"158","author":"Fuller","year":"2024","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13181-016-0551-y","article-title":"From death to death certificate: what do the dead say?","volume":"13","author":"Gill","year":"2017","journal-title":"J. Med Toxicol."},{"key":"10.1016\/j.dadr.2025.100339_bib26","article-title":"Methadone take-home policies and associated mortality: permitting versus non-permitting states","volume":"18","author":"Harris","year":"2024","journal-title":"Subst. Use"},{"issue":"6","key":"10.1016\/j.dadr.2025.100339_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.1235","article-title":"Racial, ethnic, and sex differences in methadone-involved overdose deaths before and after the US federal policy change expanding take-home methadone doses","volume":"4","author":"Harris","year":"2023","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.dadr.2025.100339_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108801","article-title":"Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: a mixed methods analysis","volume":"141","author":"Hoffman","year":"2022","journal-title":"J. Subst. Abus. Treat."},{"issue":"166","key":"10.1016\/j.dadr.2025.100339_bib29","first-page":"2013","article-title":"NCHS urban\u2013rural classification scheme for counties. National Center for Health Statistics","volume":"2","author":"Ingram","year":"2014","journal-title":"Vital.-. Health Stat."},{"key":"10.1016\/j.dadr.2025.100339_bib30","series-title":"Federal Regulation of Methadone Treatment","article-title":"US) Committee on Federal Regulation of Methadone Treatment","year":"1995"},{"key":"10.1016\/j.dadr.2025.100339_bib31","first-page":"1","article-title":"Geographic variation in availability of opioid treatment programs across U.S. communities","volume":"16","author":"Jehan","year":"2023","journal-title":"J. Addict. Dis."},{"issue":"9","key":"10.1016\/j.dadr.2025.100339_bib32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamapsychiatry.2022.1776","article-title":"Methadone\u2212involved overdose deaths in the US before and after federal policy changes expanding take\u2212home methadone doses from opioid treatment programs","volume":"79","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2025.100339_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111283","article-title":"Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations","author":"Jordan","year":"2024","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100339_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108219","article-title":"Reimagining patient-centered care in opioid treatment programs: lessons from the Bronx during COVID\u201319","volume":"122","author":"Joseph","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.dadr.2025.100339_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107968","article-title":"Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: a cross-sectional study","volume":"211","author":"Joudrey","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"13","key":"10.1016\/j.dadr.2025.100339_bib36","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive times to opioid treatment programs in urban and rural counties in 5 US States","volume":"322","author":"Joudrey","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/ewjm.172.1.11","article-title":"Toxicology and pathology of deaths related to methadone: retrospective review","volume":"172","author":"Karch","year":"2000","journal-title":"West J. Med"},{"key":"10.1016\/j.dadr.2025.100339_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2023.111579","article-title":"Examination of methadone involved overdoses during the COVID-19 pandemic","volume":"344","author":"Kaufman","year":"2023","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.dadr.2025.100339_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110876","article-title":"Validity and reliability of in-person and remote oral fluids drug testing compared to urine drug testing","volume":"250","author":"Khazanov","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100339_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109703","article-title":"Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic","volume":"242","author":"Kleinman","year":"2023","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.dadr.2025.100339_bib41","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2468-2667(23)00023-3","article-title":"Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy","volume":"8","author":"Krawczyk","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.dadr.2025.100339_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13722-021-00281-3","article-title":"Rural opioid treatment program patient perspectives on take\u2011home methadone policy changes during COVID\u201119: a qualitative thematic analysis","volume":"16","author":"Levander","year":"2021","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"2","key":"10.1016\/j.dadr.2025.100339_bib43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/1536867X1501500208","article-title":"Conducting interrupted time-series analysis for single- and multiple-group comparisons","volume":"15","author":"Linden","year":"2015","journal-title":"Stata J."},{"key":"10.1016\/j.dadr.2025.100339_bib44","first-page":"31485172","article-title":"Exploring sex differences in fentanyl-involved nonfatal overdoses using 911 dispatch data","author":"McCabe","year":"2024","journal-title":"Univ. Fla. \u2009ProQuest Diss. Theses"},{"issue":"2","key":"10.1016\/j.dadr.2025.100339_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.focus.2023.100177","article-title":"Insufficient impact: limited implementation of federal regulatory changes to methadone and buprenorphine access in Arizona during COVID-19","volume":"3","author":"Meyerson","year":"2023","journal-title":"AJPM Focus"},{"key":"10.1016\/j.dadr.2025.100339_bib46","unstructured":"Modernizing Opioid Treatment Access Act. S.644, H.R.1359 (2023-2044) 118th Congress, Second Session. Available from: \u3008https:\/\/www.markey.senate.gov\/imo\/media\/doc\/modernizing_opioid_treatment_access_act_-_2023pdf.pdf\u3009"},{"key":"10.1016\/j.dadr.2025.100339_bib47","doi-asserted-by":"crossref","unstructured":"Mulligan C. Lethal Unemployment Bonuses? Substitution and income effects on substance abuse, 2020\u221221. NBER Working Paper 29719, February 2022. Available from: https:\/\/www.nber.org\/papers\/w29719.","DOI":"10.3386\/w29719"},{"key":"10.1016\/j.dadr.2025.100339_bib48","unstructured":"National Vital Statistics System. Data are from the multiple cause of death files as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Available from: \u3008http:\/\/wonder.cdc.gov\u3009."},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13722-022-00316-3","article-title":"Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities","volume":"17","author":"Pasman","year":"2022","journal-title":"Addict. Sci. Clin. Pr."},{"issue":"2","key":"10.1016\/j.dadr.2025.100339_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/ADM.0000000000000841","article-title":"Permanent methadone treatment reform needed to combat the opioid crisis and structural racism","volume":"16","author":"Peterkin","year":"2022","journal-title":"J. Addict. Med"},{"issue":"3","key":"10.1016\/j.dadr.2025.100339_bib51","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/ruso.12307","article-title":"The opioid hydra: understanding overdose mortality epidemics and syndemics across the rural-urban continuum","volume":"85","author":"Peters","year":"2020","journal-title":"Rural Socio"},{"key":"10.1016\/j.dadr.2025.100339_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102704","article-title":"You are not clean until you're not on anything: perceptions of medication-assisted treatment in rural Appalachia","volume":"85","author":"Richard","year":"2020","journal-title":"Int J. Drug Policy"},{"key":"10.1016\/j.dadr.2025.100339_bib53","series-title":"Vital Statistics Rapid Release","article-title":"Methods to adjust provisional counts of drug overdose deaths for underreporting","author":"Rossen","year":"2018"},{"key":"10.1016\/j.dadr.2025.100339_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104302","article-title":"Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19","volume":"124","author":"Roy","year":"2024","journal-title":"Int J. Drug Policy"},{"issue":"8","key":"10.1016\/j.dadr.2025.100339_bib55","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/add.16180","article-title":"Polydrug use among patients on methadone medication treatment: evidence from urine drug testing to inform patient safety","volume":"118","author":"Saloner","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2025.100339_bib56","article-title":"The lived experiences and treatment needs of women with opioid use disorder and posttraumatic stress symptoms: a mixed methods study","volume":"161","author":"Saraiya","year":"2024","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"2","key":"10.1016\/j.dadr.2025.100339_bib57","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.amepre.2024.10.012","article-title":"Sex differences in methamphetamine mortality in the United States: heroin and fentanyl coinvolvement, 1999-2021","volume":"68","author":"Sauda","year":"2025","journal-title":"Am. J. Prev. Med"},{"key":"10.1016\/j.dadr.2025.100339_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107568","article-title":"Sex differences in prescription opioid use patterns assessed through a community engagement program in Florida","volume":"204","author":"Serdarevic","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.dadr.2025.100339_bib59","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31910","article-title":"Technology-assisted buprenorphine treatment in rural and nonrural settings: two randomized clinical trials","volume":"6","author":"Sigmon","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.dadr.2025.100339_bib60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40471-019-00201-9","article-title":"Methodological complexities in quantifying rates of fatal opioid-related overdose","volume":"6","author":"Slavova","year":"2019","journal-title":"Curr. Epidemiol. Rep."},{"key":"10.1016\/j.dadr.2025.100339_bib61","first-page":"2020","article-title":"Urban\u2013rural differences in drug overdose death rates","volume":"440","author":"Spencer","year":"2022"},{"issue":"4","key":"10.1016\/j.dadr.2025.100339_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgad064","article-title":"Enumerating contributions of fentanyls and other factors to the unprecedented 2020 rise in opioid overdose deaths: model-based analysis","volume":"2","author":"Stringfellow","year":"2023","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.dadr.2025.100339_bib63","series-title":"Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63 Publication No. PEP21\u201302\u201301\u2013002","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"key":"10.1016\/j.dadr.2025.100339_bib64","unstructured":"Substance Abuse and Mental Health Services Administration. Methadone take-home flexibilities extension guidance. Updated March 3, 2022. Available from: https:\/\/www.samhsa.gov\/medication-assisted-treatment\/statutes-regulations-guidelines\/methadone-guidance."},{"key":"10.1016\/j.dadr.2025.100339_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104214","article-title":"Get in and get out, get on with life: patient and provider perspectives on methadone van implementation for opioid use disorder treatment","volume":"121","author":"Suen","year":"2023","journal-title":"Int J. Drug Policy"},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jrh.12491","article-title":"Urban-rural disparities in opioid use disorder prevention and response activities: a cross-sectional analysis","volume":"37","author":"Swann","year":"2021","journal-title":"J. Rural Health"},{"issue":"5","key":"10.1016\/j.dadr.2025.100339_bib67","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14328","article-title":"Trends in methadone dispensing for opioid use disorder after medicare payment policy changes","volume":"6","author":"Taylor","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100339_bib68","article-title":"Issue Brief","author":"The Pew Charitable Trusts","year":"2022","journal-title":"Overv. Opioid Treat. Program Regul. State"},{"issue":"23","key":"10.1016\/j.dadr.2025.100339_bib69","article-title":"Medications for the treatment of opioid use disorder","volume":"89","author":"U.S. Department of Health and Human Services","year":"2024","journal-title":"Fed. Regist."},{"key":"10.1016\/j.dadr.2025.100339_bib70","unstructured":"U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division. Automated Reports and Consolidated Ordering System (ARCOS), Retail Drug Summary Reports, 2018, 2019, 2020, 2021, 2022. Available from: \u3008https:\/\/www.deadiversion.usdoj.gov\/arcos\/retail_drug_summary\/\u3009"},{"key":"10.1016\/j.dadr.2025.100339_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103591","article-title":"Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations","volume":"102","author":"Welsh","year":"2022","journal-title":"Int J. Drug Policy"},{"issue":"2","key":"10.1016\/j.dadr.2025.100339_bib72","article-title":"Navigating addiction treatment during COVID-19: policy insights from state health leaders","volume":"2","author":"White","year":"2024","journal-title":"Health Aff. Sch."},{"key":"10.1016\/j.dadr.2025.100339_bib73","article-title":"Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: a retrospective observational cohort study","volume":"28","author":"Williams","year":"2023","journal-title":"Lancet Reg. Health Am."},{"issue":"1","key":"10.1016\/j.dadr.2025.100339_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13011-023-00563-w","article-title":"Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff","volume":"18","author":"Wu","year":"2023","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"issue":"S2","key":"10.1016\/j.dadr.2025.100339_bib75","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.2105\/AJPH.2022.306806","article-title":"Federal and state regulatory changes to methadone take-home doses: impact of sociostructural factors","volume":"112","author":"Wyatt","year":"2022","journal-title":"Am. J. Public Health"},{"issue":"5","key":"10.1016\/j.dadr.2025.100339_bib76","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/joim.13545","article-title":"Increased mortality of patients with alcohol-related liver diseases during the COVID-19 pandemic in the United States","volume":"292","author":"Yeo","year":"2022","journal-title":"J. Intern. Med."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T23:54:59Z","timestamp":1748994899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724625000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":76,"alternative-id":["S2772724625000228"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100339","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone-involved overdose deaths in urban and rural communities before and after the public health emergency flexibilities for methadone take-home doses","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100339"}}